These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1906179)

  • 1. Expression of von Willebrand factor "Normandy": an autosomal mutation that mimics hemophilia A.
    Tuley EA; Gaucher C; Jorieux S; Worrall NK; Sadler JE; Mazurier C
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6377-81. PubMed ID: 1906179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mutation Arg (53)----Trp causes von Willebrand disease Normandy by abolishing binding to factor VIII. Studies with recombinant von Willebrand factor.
    Jorieux S; Tuley EA; Gaucher C; Mazurier C; Sadler JE
    Blood; 1992 Feb; 79(3):563-7. PubMed ID: 1732004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
    Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
    Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
    Jacquemin M
    Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of two point mutations in the von Willebrand factor gene of three families with the 'Normandy' variant of von Willebrand disease.
    Gaucher C; Mercier B; Jorieux S; Oufkir D; Mazurier C
    Br J Haematol; 1991 Aug; 78(4):506-14. PubMed ID: 1832934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autosomal recessive transmission of hemophilia A due to a von Willebrand factor mutation.
    Wise RJ; Ewenstein BM; Gorlin J; Narins SC; Jesson M; Handin RI
    Hum Genet; 1993 May; 91(4):367-72. PubMed ID: 8500791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant expression of mutations causing von Willebrand disease type Normandy: characterization of a combined defect of factor VIII binding and multimerization.
    Schneppenheim R; Lenk H; Obser T; Oldenburg J; Oyen F; Schneppenheim S; Schwaab R; Will K; Budde U
    Thromb Haemost; 2004 Jul; 92(1):36-41. PubMed ID: 15213842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations.
    Boylan B; Rice AS; De Staercke C; Eyster ME; Yaish HM; Knoll CM; Bean CJ; Miller CH;
    J Thromb Haemost; 2015 Jun; 13(6):1036-42. PubMed ID: 25780857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similarity in joint and mucous bleeding syndromes in type 2N von Willebrand disease and severe hemophilia A coexisting with type 1 von Willebrand disease in two Chinese pedigrees.
    Qin HH; Xing ZF; Wang XF; Ding QL; Xi XD; Wang HL
    Blood Cells Mol Dis; 2014 Apr; 52(4):181-5. PubMed ID: 24351655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an automated screening assay for von Willebrand disease type 2N.
    Taylor SL; Bromidge E; Savidge GF; Alhaq A
    Clin Lab Haematol; 2002 Dec; 24(6):369-75. PubMed ID: 12452818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Something new about type Normandy von Willebrand disease (type 2N VWD)?
    Mazurier C
    Thromb Haemost; 2004 Jul; 92(1):1-2. PubMed ID: 15213838
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel case of compound heterozygosity with "Normandy"/type I von Willebrand disease (vWD). Direct demonstration of the segregation of one allele with a defective expression at the mRNA level causing type I vWD.
    Siguret V; Lavergne JM; Chérel G; Boyer-Neumann C; Ribba AS; Bahnak BR; Meyer D; Piétu G
    Hum Genet; 1994 Feb; 93(2):95-102. PubMed ID: 7906671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The "Normandy" variant of von Willebrand disease: characterization of a point mutation in the von Willebrand factor gene.
    Gaucher C; Jorieux S; Mercier B; Oufkir D; Mazurier C
    Blood; 1991 May; 77(9):1937-41. PubMed ID: 2018834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.
    Michiels JJ; Gadisseur A; Budde U; Berneman Z; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Semin Thromb Hemost; 2005 Nov; 31(5):577-601. PubMed ID: 16276467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pro-polypeptide of von Willebrand factor is required for the formation of a functional factor VIII-binding site on mature von Willebrand factor.
    Leyte A; Voorberg J; Van Schijndel HB; Duim B; Pannekoek H; Van Mourik JA
    Biochem J; 1991 Feb; 274 ( Pt 1)(Pt 1):257-61. PubMed ID: 1900418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib.
    Rabinowitz I; Tuley EA; Mancuso DJ; Randi AM; Firkin BG; Howard MA; Sadler JE
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9846-9. PubMed ID: 1409710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetics of von Willebrand disease.
    Mazurier C; Ribba AS; Gaucher C; Meyer D
    Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.